Remission of Severe Eyelid Dermatitis With a Topical Janus Kinase Inhibitor

被引：2
|
作者：
Peterson, Danielle [1 ]
King, Brett [1 ]
机构：
[1] Yale Sch Med, Dept Dermatol, New Haven, CT 06510 USA
来源：
DERMATITIS | 2021年 / 32卷 / 1S期
关键词：
ATOPIC-DERMATITIS;
D O I：
10.1097/DER.0000000000000783
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：E98 / E99
页数：2
相关论文
共 50 条
  • [1] Combination of Janus kinase inhibitor and biologic for recalcitrant severe atopic dermatitis
    De Greef, Axel
    Baeck, Marie
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2025, 39 (01) : e94 - e97
  • [2] Treatment of vitiligo with the topical Janus kinase inhibitor ruxolitinib
    Rothstein, Brooke
    Joshipura, Deep
    Saraiya, Ami
    Abdat, Rana
    Ashkar, Huda
    Turkowski, Yana
    Sheth, Vaneeta
    Huang, Victor
    Au, Shiu Chung
    Kachuk, Courtney
    Dumont, Nicole
    Gottlieb, Alice B.
    Rosmarin, David
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (06) : 1054 - +
  • [3] Treatment of vitiligo with topical janus kinase inhibitor ruxolitinib
    Rothstein, B.
    Joshipura, D.
    Saraiya, A.
    Abdat, R.
    Ashkar, H.
    Turkowski, Y.
    Sheth, V.
    Huang, V.
    Au, S. Chung
    Kachuk, C.
    Dumont, N.
    Gottlieb, A. B.
    Rosmarin, D.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2017, 137 (05) : S132 - S132
  • [4] Remission of food allergy by the Janus kinase inhibitor ruxolitinib in mice
    Yamaki, Kouya
    Yoshino, Shin
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2014, 18 (02) : 217 - 224
  • [5] Janus Kinase Inhibitor Tofacitinib for Induction and Remission in ulcerative colitis
    Sandborn, W. J.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2017, 142 (14) : 1022 - 1023
  • [6] Long-term safety and efficacy of delgocitinib ointment, a topical Janus kinase inhibitor, in adult patients with atopic dermatitis
    Nakagawa, Hidemi
    Nemoto, Osamu
    Igarashi, Atsuyuki
    Saeki, Hidehisa
    Murata, Ryusei
    Kaino, Hironobu
    Nagata, Takeshi
    JOURNAL OF DERMATOLOGY, 2020, 47 (02): : 114 - 120
  • [7] Pre-Clinical Evaluation Of A Potent Janus Kinase (jak) Inhibitor Designed For Topical Delivery In Severe Asthma
    Lee, H. -H.
    Gil, M. A.
    Woodhouse, J.
    Caniga, M.
    Byford, A.
    McLeod, R.
    Jia, Y.
    Fernandes, R.
    Naber, J.
    Witter, D.
    Cicmil, M.
    Salmon, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [8] Innovation in the treatment of atopic dermatitis: Emerging topical and oral Janus kinase inhibitors
    Nakashima, Chisa
    Yanagihara, Shigeto
    Otsuka, Atsushi
    ALLERGOLOGY INTERNATIONAL, 2022, 71 (01) : 40 - 46
  • [9] Efficacy of topical tofacitinib, a Janus kinase inhibitor, in the treatment of plaque psoriasis
    Bagherani, Nooshin
    Smoller, Bruce R.
    DERMATOLOGIC THERAPY, 2017, 30 (03)
  • [10] Topical Tofacitinib: A Janus Kinase Inhibitor for the Treatment of Vitiligo in an Adolescent Patient
    Berbert Ferreira, Sineida
    Berbert Ferreira, Rachel
    Neves Neto, Afonso Cesar
    Assef, Silvana Martins Caparroz
    Scheinberg, Morton
    CASE REPORTS IN DERMATOLOGY, 2021, 13 (01): : 190 - 194
12345